Stocktoria
BIO-TECHNE Corp TECH
BIO-TECHNE Corp statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($11.15); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
P / E vs its own history
BIO-TECHNE Corp trades at about 157× earnings — above its 10-year norm (10-year range 40.1×–138.6×, median 58×).
Shaded band = 10-year range (40.1×–138.6×); dot = today's 157×.
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 64.8% | 66.4% | 67.7% | 68.4% | 68.0% | 65.4% | 66.3% | 67.2% | 66.5% | 67.5% |
| Operating margin | 8.4% | 17.8% | 26.3% | 26.8% | 25.5% | 21.3% | 20.5% | 21.2% | 21.4% | 30.2% |
| Net margin | 6.0% | 14.5% | 25.1% | 24.6% | 15.1% | 31.0% | 13.5% | 19.6% | 13.5% | 20.9% |
| FCF margin | 21.0% | 20.4% | 19.0% | 25.4% | 33.1% | 20.8% | 21.9% | 23.2% | 22.8% | 25.5% |
| Return on assets | 2.9% | 6.2% | 10.8% | 11.9% | 6.2% | 11.3% | 5.1% | 7.9% | 4.9% | 9.2% |
| Return on equity | 3.8% | 8.1% | 14.5% | 16.0% | 8.9% | 16.6% | 8.2% | 11.7% | 8.0% | 11.9% |
| Current ratio | 3.46 | 3.87 | 4.84 | 3.44 | 3.35 | 4.88 | 4.05 | 5.01 | 2.57 | 4.69 |
Computed from company filings · US · as of 2025-06-30. Facts plus Stocktoria's own computed scores — not investment advice.